会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 114. 发明公开
    • 블라디놀 F를 이용한 항염증성 조성물
    • 使用VLADINOL F的抗炎组合物
    • KR1020130071666A
    • 2013-07-01
    • KR1020110139005
    • 2011-12-21
    • 재단법인 제주테크노파크
    • 윤원종함영민정용환박수영오대주
    • A61K31/343A61K31/045A61P29/00
    • A61K36/60A61K31/12
    • PURPOSE: An anti-inflammatory composition using vladinol F isolated from F. erecta var. sieboldii is provided to suppress generation of NO, PGE2 (prostaglandin), and inflammatory cytokines (TNF-alpha, IL-1beta, and IL-6). CONSTITUTION: An anti-inflammatory composition contains vladinol F as an active ingredient. A method for isolating vladinol F from F. erecta var. sieboldii comprises the steps of: dipping F. erecta var. sieboldii leaves, stems, or a mixture thereof in a mixture solvent of ethanol and water and preparing a power extract; suspending the extract in distilled water, and sequentially fractioning to obtain a dichloromethane fraction; coating a celite surface with the fraction and performing column chromatography using hexane, dichloromethane, ethyl acetate, and methanol to obtain 4 purified materials; performing normal phase column chromatography of a second purified material using hexane:ethyl acetate:methanol (1:2:0.2, v/v) to obtain total 20 purified materials; performing normal phase silicagel column chromatography of 16th purified material among 20 purified materials using chloroform:methanol (10:1, v/v) and preparing total 18 purified materials; and collecting 9th purified material among 18 purified materials. [Reference numerals] (AA) MC fraction of a F. erecta var. sieboldii extract (11.2g); (BB) Column chromatography; (CC) Normal phase silica gel (5cm×60cm); (DD) Normal phase silica gel (2.0cm×50cm)
    • 目的:使用从F. erecta var。分离的vladinol F的抗炎组合物。 提供sieboldii以抑制NO,PGE2(前列腺素)和炎性细胞因子(TNF-α,IL-1β和IL-6)的产生。 构成:抗炎组合物含有vladinol F作为活性成分。 一种从F. erecta var。中分离vladinol F的方法。 sieboldii包括以下步骤:浸渍F.frecta var。 sieboldii叶,茎或其在乙醇和水的混合溶剂中的混合物,并制备动力提取物; 将提取物悬浮在蒸馏水中,并依次分级得到二氯甲烷馏分; 用级分涂覆硅藻土表面,并使用己烷,二氯甲烷,乙酸乙酯和甲醇进行柱层析,得到4种纯化物; 使用己烷:乙酸乙酯:甲醇(1:2:0.2,v / v)进行第二纯化物质的正相柱色谱,得到总共20种纯化物质; 使用氯仿:甲醇(10:1,v / v)在20个纯化物中进行第16次纯化物质的正相硅胶柱色谱,并制备总共18种纯化物质; 并在18种纯化材料中收集第9种纯化材料。 (参考数字)(AA)MC分数F.frecta var。 sieboldii提取物(11.2g); (BB)柱色谱; (CC)正相硅胶(5cm×60cm); (DD)正相硅胶(2.0cm×50cm)
    • 120. 发明公开
    • 항염활성 및 골대사 관련인자 억제활성을 나타내는까마귀쪽나무 추출물
    • 具有抗炎活性和骨代谢因子抑制活性的LITSEA JAPONICA提取物
    • KR1020080020738A
    • 2008-03-06
    • KR1020060083944
    • 2006-09-01
    • 재단법인 제주테크노파크
    • 박수영정용환윤원종이정아김지영오대주유은숙이혜자
    • A61K36/54A61P39/06
    • A61K36/54A23V2200/304A61K2236/33Y10S514/825
    • A composition comprising the extract of Litsea japonica is provided to prevent and treat inflammatory disease and metabolic bone disease including osteoporosis and osteopetrosis by inhibiting inflammation and bone metabolic factors including IL-6(interleukin-6), COX-2(cyclooxygenase-2) and PGE2(prostaglandin E2) without side effects. A composition for preventing and treating inflammatory disease and metabolic bone disease comprises the extract of Litsea japonica which is prepared by drying leaf, stem or fruit of Litsea japonica juss in the shade, pulverizing the dried Litsea japonica juss, dipping the pulverized Litsea japonica juss in 80% ethanol, sonicating the Litsea japonica juss solution for 1 hour, repeating the sonication in three times to prepare the ethanol extract of Litsea japonica juss, collecting the supernatant and concentrating the supernatant under reduced pressure, suspending the concentrate in distilled water, and extracting the suspension with hexane, dichloromethane, ethyl acetate and butanol sequentially, and is formulated as food additives or drink.
    • 提供包含日本蓟马提取物的组合物,通过抑制炎症和包括IL-6(白细胞介素-6),COX-2(环氧合酶-2)和骨质疏松素-2)在内的骨代谢因子来预防和治疗包括骨质疏松和骨质疏松的炎性疾病和代谢性骨病, PGE2(前列腺素E2)无副作用。 用于预防和治疗炎性疾病和代谢性骨疾病的组合物包括通过在树荫下干燥荔枝枣的叶,茎或果实制备的荔枝提取物,粉碎干燥的枸杞,将粉碎的荔枝粳稻 80%乙醇,将Litsea japonica juss溶液超声处理1小时,三次重复超声处理,制备日本it杷的乙醇提取物,收集上清液,减压浓缩上清液,将浓缩物悬浮于蒸馏水中,萃取 依次用己烷,二氯甲烷,乙酸乙酯和丁醇悬浮,配制成食品添加剂或饮料。